Advik Laboratories Ltd — Important, 14-10-2025: Company Update

MPS Pharmaa Limited has reported its investor complaint status for the quarter ending September 30, 2025. The company confirmed that no investor complaints were pending at the start of the quarter, none were received during the period, and consequently, no complaints were disposed of or remained unresolved at the quarter's end. This indicates the company's robust processes for handling shareholder grievances, ensuring a clear record of zero unresolved issues. For investors, this reflects positively on operational transparency and responsiveness in addressing stakeholder concerns.